Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues

Genes Chromosomes and Cancer

Volumn 41, Issue 3, 2004, Pages 232-242

  Petursdottir, Thorgunnur Eyfjord ^a   Thorsteinsdottir, Unnur ^b   Jonasson, Jon Gunnlaugur ^a,c   Moller, Pall Helgi ^a   Huiping, Chen ^d   Bjornsson, Johannes ^a   Egilsson, Valgardur ^a   Imreh, Stefan ^e   Ingvarsson, Sigurdur ^d  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b DECODE GENETICS   (Iceland)

^c ICELANDIC CANCER REGISTRY   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CHROMOSOME 3; CHROMOSOME 3 COMMON ELIMINATED REGION 1; CHROMOSOME 3P; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; CHROMOSOME MAP; CONTROLLED STUDY; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYBRID; INTERSTITIAL CHROMOSOME DELETION; MARKER GENE; PRIORITY JOURNAL; SCID MOUSE; SOFT TISSUE SARCOMA; SOLID TUMOR; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MODELS, GENETIC; NEOPLASM PROTEINS; NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 4644238708     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20072     Document Type: Article

References (33)

1. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. 1994. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54:2310-2312.
2. Braga EA, Kashuba VI, Malyukova AV, Loginov VI, Senchenko VN, Bazov IV, Kisselev LL, Zabarovsky ER. 2003. New tumor suppressor genes in hot spots of human chromosome 3: New methods of identification. Mol Biol 37:170-185.
3. Crawford AW, Pino JD, Beckerle MC. 1994. Biochemical and molecular characterization of the chicken cysteine-rich protein, a developmentally regulated LIM-domain protein that is associated with the actin cytoskeleton. J Cell Biol 124:117-127.
4. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ, Huebner K, Croce CM. 2001. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Nad Acad Sci USA 98:3346-3351.
5. Eiriksdottir G, Bergthorsson JT, Sigurdsson H, Gudmundsson J, Skirnisdottir S, Egilsson V, Barkardottir RB, Ingvarsson S. 1995. Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: correlation with clinical variables. Int J Oncol 6:369-375.
6. Imreh S, Kholodnyuk I, Allikmetts R Stanbridge EJ, Zabarovsky ER, Klein G. 1994. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Genes Chromosomes Cancer 11: 237-245.
7. Imreh S, Klein G, Zabarovsky ER. 2003. Search for unknown tumor antagonizing genes. Genes Chromosomes Cancer 38:307-321.
8. Ingvarsson S, Sigbjornsdottir BI, Huiping C, Jonasson JG, Agnarsson BA. 2001. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival. Cancer Detect Prev 25:292-298.
9. Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM. 2001. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 61:1578-1584.
10. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. 1999. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res 59:3333-3339.
11. Kholodnyuk I, Kost-Alimova M, Kashuba V, Szeles A, Stanbridge EJ, Zabarovsky ER, Klein G, Imreh S. 1997. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice. Genes Chromosomes Cancer 18:200-211.
12. Kiss H. Kedra D, Yang Y, Kost-Alimova M, Kiss C, O'Brien KP, Fransson I, Klein G, Imreh S, Dumanski JP. 1999. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum Genet 105:552-559.
13. Kiss H, Yang Y, Kiss C, Andersson K, Klein G, Imreh S, Dumanski JP. 2002. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. Eur J Hum Genet 10:52-61.
14. Kok K, van den Berg A, Veldhuis PM, van der Veen Ay, Franke M, Schoenmakers EF, Hulsbeek MM, van der Hout AH, de Leij L, van de Ven W. 1994. A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res 54:4183-4187.
15. Kost-Alimova M, Kiss H, Federova L, Yang Y, Dumanski JP. Klein G and Imreh S. 2003. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3. Proc Natl Acad Sci USA 100:6622-6627.
16. Kost-Alimova M, Fedorova L, Yang Y, Klein G, Imreh S. 2004. Microcell mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late replicating regions. Genes Chromosomes Cancer, 40:316-324.
17. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, Sümegi J. 1988. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85:1571-1575.
18. Lerman MI and Minna JD, The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. 2000. The 630 kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 60:6116-6133.
19. LiFu Hu, Eiriksdottir G, Lebedeva T, Kholodnyouk I, Alimov A, Chen F, Luo Y, Zabarovsky ER., Ingvarsson S, Klein G, Ernberg I. 1996. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer 17:118-126.
20. Manes S, Mira E, Colomer R, Montero S, Real LM, Gomez-Mouton C, Jimenez-Baranda S, Garzon A, Lacalle RA, Harshman K, Ruiz A, Martinez C. 2003. CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med 189:1381-1389.
21. Maynard Ma, Ohh Michael. 2004. von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol 24:1-13.
22. Petursdottir ThE, Hafsteinsdottir SH, Jonasson JG, Moller PH, Thorsteinsdottir U, Huiping C, Egilsson V, Ingvarsson S. 2002. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients. Anticancer Res 22:3205-3512.
23. Richards RI. 2001. Fragile sites and unstable chromosomes in cancer: causes and consequences. TIG 17:339-345.
24. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce CM, Pierotti MA, Sozzi G. 1999. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and cell cycle control. Proc Natl Acad Sci USA 96:8489-8492.
25. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K. 1997. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94:13771-13776.
26. Smith SA, Easton DF, Evans DG, Ponder BA. 1992. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild type chromosome. Nat Genet 2:128-131.
27. Szeles A, Yang Y, Sandlund AM, Kholodnyuk I. Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G, Imreh S. 1997. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer 20:329-336.
28. Vignal A, Gyapay G, Hazan J, Nguyen S, Dupraz C, Cheron N, Becuwe N, Tranchant M, Weissenbach J. 1993. Non-radioactive multiplex procedure for genotyping of microsatellite markers. In: Adolph KW, editor. Methods in molecular genetics; gene and chromosome analysis. San Diego, CA: Academic Press, p 211-221.
29. Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schroder JK, Bardenheuer W, Seeber S, Huebner K, Schutte J, Opalka B. 2000. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. Cancer Res 60: 2780-2785.
30. Yang Y, Kiss H, Kost-Alimova M, Kedra D, Fransson I, Seroussi E, Li J, Szeles A, Kholodnyuk I, Imreh MP, Fodor K, Hadlaczky G, Klein G, Dumanski JP, Imreh S. 1999. A 1-Mb PAC contig spanning the common eliminated region 1 (CER 1) in microcell hybrid-derived SCID tumors. Genomics 62:147-155.
31. Yang Y, Alimova MK, Ingvarsson S, Qianhui Q, Kiss H, Szeles A, Cuthbert A, Klein G, Imreh S. 2001. "Elimination test (Et)" identifies similar 3p regions, including CER 1 at 3p21.3, in the human/human and in human/mouse microcell hybrid derived tumors. Proc Nad Acad Sci USA 98:1136-1141.
32. Yang Y, Li JF, Szeles A, Imreh MP, Kost-Alimova M, Kholodnyuk I, Fedorova L, Darai E, Klein G, Imreh S. 2003. Consistent downregulation of human lactoferrin (LF) gene expressed in A9 murine fibrosarcoma cells, following tumor growth in SCID mice. Cancer Letters 191:155-164.
33. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rudiger T, McCue PA, Croce CM, Huebner K. 2001. The tumor spectrum in FHlT-deficient mice. Proc Nad Acad Sci USA 98: 10250-10255.